Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-036692
Filing Date
2022-06-14
Accepted
2022-06-14 16:23:47
Documents
1
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4080
  Complete submission text file 0001209191-22-036692.txt   5573
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O UNITEDHEALTH GROUP INCORPORATED 9900 BREN ROAD EAST MINNETONKA MN 55123
Business Address
Tuckson Reed Vaughn (Reporting) CIK: 0001511051 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 221015155